Latest Global Markets News

Citigroup Global Markets Australia has announced a fully franked dividend of AUD 2.2675 for RIO CitiFirst Self-Funding Instalment MINI warrants, aligning key dates with RIO ordinary shares.

EV Resources has launched a critical exploration program at its Los Lirios Antimony Project in Mexico, aiming to quantify high-grade deposits and accelerate near-term production to capitalize on a tightening global market.

Eden Innovations Ltd has announced a non-renounceable entitlement offer to raise approximately $5.7 million, issuing new shares at $0.035 each alongside free options exercisable at $0.07. The capital raise aims to support business expansion and debt reduction.

OD6 Metals has successfully produced high-quality rare earth products from its Splinter Rock project, positioning itself for premium market payability and strategic global partnerships.

New Frontier Minerals has collected a significant bulk sample from its Cusp Prospect and identified a new mineralised target, Headingley, as it prepares for its inaugural drilling campaign at the Harts Range Project.

RooLife Group Ltd has successfully raised $2 million through an oversubscribed strategic placement, positioning the company to expand its e-commerce footprint across key international markets.

Rimfire Pacific Mining reports robust scandium assay results from its inaugural scandium-focused drilling at Currajong, setting the stage for a maiden resource estimate in September 2025.

IODM Limited has triggered a significant increase in its guaranteed minimum monthly revenue from its UK Education segment, reflecting a remarkable 242% growth in July 2025 compared to last year. This milestone boosts the annualised minimum payment to AUD 2.39 million, underscoring the strength of its digital accounts receivable platform.

Noxopharm Limited has successfully completed the second dose cohort in its HERACLES Phase 1 trial for SOF-SKN™, confirming safety and tolerability and moving forward to a higher dose. This progress marks a key step in developing a novel autoimmune disease treatment.

AVITA Medical has filed its Q2 2025 Form 10-Q, reaffirming its leadership in acute wound care with its FDA-approved RECELL System and expanding international footprint.

Memphasys Limited pivots from development to commercial execution with its flagship IVF product Felix, targeting global markets through direct sales and recurring revenue streams.

OD6 Metals reports significant metallurgical advancements at its Splinter Rock Rare Earth Project, integrating Ion Exchange technology to enhance impurity removal and increase recovery rates. These improvements promise to materially improve project economics and broaden market appeal.